A Study on the Pathogenesis and Determinants of Intravenous Leiomyomatosis
NCT ID: NCT06773819
Last Updated: 2025-02-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
30 participants
OBSERVATIONAL
2025-05-01
2027-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Does HPV infection promote the development of IVL from uterine leiomyoma? Surgical sections and HPV-DNA test results will be collected in participants diagnosed with IVL or uterine leiomyoma.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
HPV Integration and Tumorigenesis of Uterine Cervical Adenocarcinoma
NCT03742869
A Cohort Study for the Following up of Conization
NCT03961178
A Multicenter Cohort Study of HPV Viral Load in Predicting the Postoperative Recurrence of HSIL
NCT05282745
DNA Methylation for Screening Uterine Cervical Lesions: A Case-control Study
NCT03961191
All-cause and Diseases-specific Mortality of High-risk HPV Infection
NCT06631495
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Be able to understand and sign the informed consent
Exclusion Criteria
* Pregnant or lactating female
* Postoperative pathology do not include IVL or uterine leiomyoma
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Peking Union Medical College Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IVL001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.